Blockchain dates back to the 2000s, but it only entered the mainstream in 2017. That year, it neared the peak of the Gartner Hype Cycle, a visual index of how much attention emerging technologies garner for their business-level potential. By the end of 2017, the trading prices of prominent digital currencies such as Bitcoin and […]
Category: Independent Medical Reviews
Did you know that more than 10,000 baby boomers reach retirement age every single day? It’s a staggering figure, but it makes sense considering the overall size of their generation. Born between 1946 and 1964, they are one of the largest population cohorts in U.S. history, with approximately 74 million members alive through 2016. Their […]
Leah Williams is the Recruitment and Credentialing Manager at Advanced Medical Reviews. In this week’s segment of “Insights From The Inside” Leah shares her perspective on the importance of quality care. So you have the most contact with AMR’s Physician network. If you had to name one quality that healthcare professionals share, what would […]
The second blog in a series from AMR’s management leadership – “Insights from the Inside” – in which Megan Kaufman, General Manager of AMR, shares her insights on the patient-payer relationship. Too often, claims and appeals processes are portrayed in a way that pits Payers against Patients in the battle for patient wellness and quality […]
The first blog in a series from AMR’s management leadership – “Insights from the Inside” – in which we highlight and share our insights, philosophy, and values, as they relate to our work at AMR. When I reflect on my management philosophy, I’m reminded of something Peter Drucker said, “so much of what we […]
Unlike national programs such as Supplemental Security Income and state-federal partnerships like Medicaid, the structure and the funding of WC initiatives are entirely determined by statehouses.
With the benefits of stability and high demand, it is easy to understand what drives many undergraduates to pursue a career in medicine.
The gold standard for evidence for EBM – randomized controlled trials (RCTs) – only emerged in the 20th century.
Millennials will confront mounting human and economic costs of these chronic conditions, along with emerging problems such as antibiotic resistance.
What can providers and payers do, beyond tech upgrades, to more closely align their services with millennial expectations?